HOT TOPICS in Buprenorphine Treatment Webinars
Overview of Addiction
Addiction: A Chronic Relapsing Disease
Screening for Substance Use Disorders
NIDAMED - Resources to Help Physicians Screen for Drug Use
Embedding Addiction Services in General Medicine
Initial Interaction and Screening of the Co-Morbid Pain Patient with Problem Opiate Use
Clinical Use of Buprenorphine
Integrating Buprenorphine Treatment in Primary Care
Buprenorphine Induction and Appropriate Dosing
Managing Co-Occurring Addictions
Medical Co-morbidities
Practical Suggestions for Improving Your Results Using Buprenorphine
Opioid Maintenance: Terminable or Interminable
Newer Formulations of Buprenorphine
Minimizing the Risks of Buprenorphine Diversion and Misuse from Office Based Treatment
The Use of Buprenorphine in the Treatment of Prescription Opioid Dependence
Models of Buprenorphine Induction
Comparison of Effectiveness of Methadone vs Buprenorphine Maintenance Treatment
Implementing Antagonist-Based Relapse Prevention Treatment for Buprenorphine-Treated Individuals
Focus on Marijuana: Current Risks and Controversies
Poly-Substance Abuse in Office-Based Buprenorphine Treatment
Integrating Buprenorphine/Naloxone Into An Opioid Treatment Program
Pain Management in Patients on Buprenorphine Maintenance
Management of Buprenorphine Side Effects
Special Populations
Inducting and Stabilizing Opioid-Dependent Pregnant Women on Methadone or Buprenorphine: Current Research
and Future Treatment Implications
Buprenorphine Treatment of Opioid Dependence in Adolescents and Young Adults
Buprenorphine Treatment in Rural Communities
Buprenorphine Treatment During Pregnancy
Psychosocial interventions
Lessons Learned from Addiction Psychiatry: The Motivational Interviewing Approach to Change
Network Therapy: Using the Patient’s Family and Peer Support for Effective Office Practice
Office Management and Reimbursement
What Waivered Physicians Need to Understand About DEA Requirements
The Business Case for Opioid-Dependence and Alcohol-Dependence Medications
Enhancing Access to Prescription Drug Monitoring Programs Through Health Information Technology
Confidentiality of Substance Abuse Treatment Records
Opioid Dependence and the Future of Treatment: Buprenorphine in the VA